NOAH Compendium

Printed from NOAH Compendium ( (c) Copyright NOAH Compendium 2021. All Rights Reserved.
Date: Friday, May 7, 2021 17:05

Description: Ceva logo
Release 2.199
Adaxio® Shampoo for dogs
Species: Dogs
Therapeutic indication: Pharmaceuticals: Antimicrobials: Topical preparations: Skin
Active ingredient: Chlorhexidine digluconate, Miconazole Nitrate
Product:Adaxio® Shampoo for dogs
Product index: Adaxio
Qualitative and quantitative composition
Each ml contains:
Active substances:
Chlorhexidine digluconate 20 mg (equivalent to chlorhexidine 11.26 mg)
Miconazole nitrate 20 mg (equivalent to miconazole 17.37 mg)
Methylchloroisothiazolinone 0.0075 mg
Methylisothiazolinone 0.0025 mg
Benzoic acid (E210) 1,35 mg
For a full list of excipients, see Pharmaceutical particulars
Pharmaceutical form
Shampoo. A clear light yellow to yellow liquid.
Clinical particulars
Target species
Indications for use, specifying the target species
For the treatment and control of seborrhoeic dermatitis associated with Malassezia pachydermatis and/or Staphylococcus pseudintermedius.
Do not use in case of hypersensitivity to the active substances or to any of the excipients.
Special warnings for each target species
In order to prevent recurrence of the infection, appropriate control methods should be employed in the animal’s environment (e.g. cleaning and disinfection of kennel, beds.
Special precautions for use
Special precautions for use in animals
Official, national and regional antimicrobial policies should be taken into account when the product is used. Take care to avoid the animal inhaling the product or getting it into eyes, auditory canal, nose or mouth during shampooing. In case of accidental contact with eyes, rinse with plenty of water. If eye irritation persists, consult a veterinarian. Do not allow the animal to lick itself during shampooing and rinsing, or before it is dried. Puppies should not come into contact with nursing females after treatment until the coat has dried. Use of the product deviating from the SPC's recommendations may induce a resistance in the population of skin bacteria.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
∙ People with known hypersensitivity to chlorhexidine, miconazole or any of the excipients should avoid contact with the product.
∙ This product may cause hypersensitivity following dermal contact. If you develop symptoms following exposure such as skin rash, you should seek medical advice and show the physician the label or package leaflet.
∙ Accidental eye contact with undiluted product may cause serious eye irritation. Avoid contact with the eyes. In case of accidental contact with eyes, rinse with plenty of water. If irritation persists consult your physician.
∙ The product can be irritating to skin. Avoid prolonged contact with the shampoo by gently washing and drying hands.
∙ Avoid excessive handling and stroking of treated animals immediately following treatment.
Adverse reactions (frequency and seriousness)
Skin reactions such as itching and redness may occur very rarely. Pruritic and/or erythematous reaction may appear very rarely in an atopic dog.
Use during pregnancy or lactation
Studies in animals have not produced any teratogenic, foetotoxic or maternotoxic effects due to chlorhexidine or miconazole at the recommended doses. The safety of the product has not been established during pregnancy and lactation. Use only accordingly to the benefit/risk assessment by the responsible veterinarian and see Special precautions for use)
Interaction with other medicinal products and other forms of interaction
No data are available to evaluate interactions with other topically applied products.
Amounts to be administered and administration route
Cutaneous use. As a general rule, shampoo twice weekly until the symptoms subside and weekly thereafter or as necessary to keep the condition under control.
Wet the animal thoroughly with clean water and apply the product to the animal at several points and massage into the coat. Use sufficient to raise a lather on the coat and skin. Ensure that the shampoo is applied around the lips, under the tail and between the toes. Allow the animal to stand for 10 minutes, then rinse off with clean water and leave to dry naturally in a warm, draught-free environment.
Number of treatments per 200 ml bottle
Number of treatments per 500 ml bottle
Short hair
Long hair
Short hair
Long hair
Up to 15 kg
16-24 kg
25 kg or more
Overdose (symptoms, emergency procedures, antidotes), if necessary
No data available.
Pharmacological particulars
Pharmacotherapeutic group: Dermatological. ATCvet code: QD08AC52.
Pharmacodynamic properties
Chlorhexidine digluconate
Chlorhexidine digluconate (ATCvet classification QD08AC02) is a Bisbiguanide antimicrobial agent against Gram-positive and Gram-negative bacteria. It is both bactericidal and bacteriostatic depending on the concentration used. Growth inhibition is achieved by a direct effect on ATP-ase so interfering with the energy transport mechanisms. The bactericidal effect of chlorhexidine results from coagulation of the bacterial cell contents. Chlorhexidine digluconate is incorporated in the product for its activity against Staphylococcus pseudintermedius. Typical MIC values found in clinical Staphylococcus pseudintermedius isolates are 2.0 mg/L (2015). Staphylococcus pseudintermedius resistance to chlorhexidine has not been reported.
Miconazole nitrate
Miconazole nitrate (ATCvet classification QD01AC02) is an imidazole antifungal agent with activity against yeasts such as Malassezia pachydermatis.
It is both fungicidal and fungistatic depending on the concentration used. Miconazole inhibits ergosterol incorporation into cell membranes so increasing concentrations of cytotoxic hydrogen peroxide within the fungal cell wall. Miconazole nitrate has been incorporated in the product for its activity against Malassezia pachydermatis. Typical MIC values found in clinical Malassezia pachydermatis isolates are 1 – 4.0 µg/mL (2012). Malassezia pachydermatis resistance to miconazole has not been reported.
Pharmacokinetic particulars
Chlorhexidine digluconate
High concentrations of chlorhexidine digluconate are achieved in the hair coat and on the skin for the 10 minute period following shampooing. These concentrations are well in excess of the MICs for Staphylococcus pseudintermedius. Chlorhexidine digluconate is poorly absorbed from the gastrointestinal tract on ingestion. There is little or no percutaneous absorption. In humans it has been shown that 26% remains on the skin at 29 hours after application.
Miconazole nitrate
High concentrations of miconazole nitrate are achieved in the hair coat and on the skin for the 10 minute period following shampooing. These concentrations are well in excess of the MICs for Malassezia pachydermatis. There is little absorption through skin or mucous membranes when applied topically.
Pharmaceutical particulars
List of excipients
Methylchloroisothiazolinone, Methylisothiazolinone, Macrogol lauryl ether, Cocamidopropyl betaine, Disodium cocoamphodiacetate, Cetrimonium chloride, Macrogol 120 methyl glucose dioleate, Magnesium chloride, Sodium chloride, Magnesium nitrate, Citric acid monohydrate (for pH adjustement), Benzoic acid (E210), Water, purified
Major incompatibilities
None known.
Shelf life
Shelf-life of the veterinary medicinal product as packaged for sale: 24 months
Shelf-life after first opening the immediate packaging: 3 months.
Special precautions for storage
Do not store above 25°C. Do not refrigerate or freeze.
Nature and composition of immediate packaging
The container is a white opaque polypropylene bottle with a polypropylene flip top cap.
Bottle of 200 ml
Bottle of 500 ml
Box of 1 bottle of 200 ml
Box of 1 bottle of 500 ml
Not all pack sizes may be marketed
Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Marketing Authorisation Holder (if different from distributor)
Marketing Authorisation Number
Vm 15052/4090
Significant changes
Date of the first authorisation or date of renewal
20 November 2014
Date of revision of the text
15 August 2019
Any other information
Legal category
Legal category: POM-V
GTIN description:Adaxio 200 ml